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Aims Transient Receptor Potential Melastatin 7 (TRPM7) cation channel is a chanzyme (channel þ kinase) that influences
cellular Mg2þ homeostasis and vascular signalling. However, the pathophysiological significance of TRPM7 in the car-
diovascular system is unclear. The aim of this study was to investigate the role of this chanzyme in the cardiovascu-
lar system focusing on inflammation and fibrosis.
....................................................................................................................................................................................................
Methods
and results
TRPM7-deficient mice with deletion of the kinase domain (TRPM7þ/Dkinase) were studied and molecular mecha-
nisms investigated in TRPM7þ/Dkinase bone marrow-derived macrophages (BMDM) and co-culture systems with car-
diac fibroblasts. TRPM7-deficient mice had significant cardiac hypertrophy, fibrosis, and inflammation. Cardiac colla-
gen and fibronectin content, expression of pro-inflammatory mediators (SMAD3, TGFb) and cytokines [interleukin
(IL)-6, IL-10, IL-12, tumour necrosis factor-a] and phosphorylation of the pro-inflammatory signalling molecule
Stat1, were increased in TRPM7þ/Dkinase mice. These processes were associated with infiltration of inflammatory
cells (F4/80þCD206þ cardiac macrophages) and increased galectin-3 expression. Cardiac [Mg2þ]i, but not [Ca
2þ]i,
was reduced in TRPM7þ/Dkinase mice. Calpain, a downstream TRPM7 target, was upregulated (increased expression
and activation) in TRPM7þ/Dkinase hearts. Vascular functional and inflammatory responses, assessed in vivo by intra-
vital microscopy, demonstrated impaired neutrophil rolling, increased neutrophil: endothelial attachment and trans-
migration of leucocytes in TRPM7þ/Dkinase mice. TRPM7þ/Dkinase BMDMs had increased levels of galectin-3, IL-10,
and IL-6. In co-culture systems, TRPM7þ/Dkinase macrophages increased expression of fibronectin, proliferating cell
nuclear antigen, and TGFb in cardiac fibroblasts from wild-type mice, effects ameliorated by MgCl2 treatment.
....................................................................................................................................................................................................
Conclusions We identify a novel anti-inflammatory and anti-fibrotic role for TRPM7 and suggest that its protective effects are
mediated, in part, through Mg2þ-sensitive processes.
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Graphical Abstract
1. Introduction
Transient Receptor Potential Melastatin 7 cation channel (TRPM7) is
a ubiquitously expressed channel fused to a C-terminal a-kinase do-
main located in intracellular vesicles and in the plasma membrane,1,2
with important roles in vascular regulation, hypertension,3,4 tumour
progression,5 and immune activation.6,7 The channel is permeable pri-
marily not only to Mg2þ but also to Zn2þ and Ca2þ, and the a-ki-
nase influences activity of downstream target proteins including
annexin-1, calpain-II, myosin IIA, eukaryotic elongation factor 2-kinase
(eEF2-k), and phospholipase Cc2 (PLCc2).4,8 TRPM7 has autophos-
phorylation residues and cleavage of the a-kinase releases fragments
that bind to transcription factors resulting in epigenetic mod-
ifications.9 The essential and non-redundant function of TRPM7 in de-
velopment was demonstrated in mice where TRPM7 and TRPM7
a-kinase knockout resulted in embryonic lethality.10 We showed that
cells deficient in the a-kinase domain of TRPM7 exhibit a pro-
inflammatory phenotype with increased expression of ICAM-1, cyclo-
oxygenase-2 (COX-2) and plasminogen activator inhibitor-1 (PAI-1)
upon aldosterone stimulation.11 TRPM7-kinase deficient heterozygous
mice are viable, however, they develop hypomagnesaemia, vascular
dysfunction and are hyper-responsive to the blood pressure-elevating
effects of angiotensin II (Ang II).3
Chronic low-grade inflammation plays an important pathophysiologi-
cal role in cardiovascular disease as evidenced by immune cell activation,
production of inflammatory mediators, tissue injury, and organ dam-
age.12 These inflammatory responses are accompanied by fibrosis, lead-
ing to cardiovascular complications, including heart and kidney injury and
vascular dysfunction. Recruited monocytes/macrophages and lympho-
cytes produce pro-inflammatory mediators, such as tumour necrosis
factor-a (TNFa), interleukins (ILs) (IL-6, IL-1b, IL-12), monocyte chemo-
attractant protein-1 (MCP-1), and reactive oxygen species (ROS) that
activate transcription factors, including Stat1 and Stat3.13 Production of
pro-fibrotic mediators including transforming growth factor-b1 (TGF-
b1), PAI-1, osteoponin, and galectin-3 (Gal-3) are also implicated in
cardiovascular injury and target organ damage.14
TRPM7 dysregulation is associated with cell injury and inflammation in
various pathologies. Inhibition of TRPM7 in rheumatoid arthritis
fibroblast-like synoviocytes, caused endoplasmic reticulum stress, inflam-
mation and apoptosis15 and in HEK-293 cells overexpressing TRPM7,
there was cell rounding and loss of adhesion with associated increased
oxidative stress.16 TRPM7-deficient chicken B cell (DT-40) growth was
arrested, which was rescued by exogenous Mg2þ supplementation.17
TRPM7 deletion in T cell lineage showed reduction in CD4þ and CD8þ
T cells.18 Deletion of TRPM7 channel in megakaryocytes leads to macro-
thrombocytopenia.19 In macrophages, pharmacologic inhibition of
TRPM7 reduced macrophage polarization towards an M2 anti-
inflammatory phenotype.20 In the vascular system, TRPM7 inhibition re-
duced calcification in VSMCs21 and disruption of platelet TRPM7-kinase
activity protected the brain from cerebral inflammation and thrombus
formation.22 We demonstrated that TRPM7 expression is regulated by
vasoactive mediators4,23 and that aldosterone regulates TRPM7 channel
activity. In experimental hypertension, TRPM7-kinase is protective and
in vitro data showed that the TRPM7 a-kinase deletion is associated with
enhanced vascular ROS production and stimulation of pro-inflammatory
signalling pathways.3,11
Together the above studies suggest that TRPM7 is associated with
both protective and injurious effects. However, most studies were per-
formed in in vitro cell-based models. The pathophysiological relevance of
TRPM7 in vivo is elusive, especially with respect to the cardiovascular
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system. To address this, we deeply phenotyped heterozygous TRPM7-
deficient mice (TRPM7þ/Dkinase) focusing on inflammatory and fibrotic
processes in the heart, vasculature and kidneys. We also explored the
role of macrophages in these processes and investigated putative molec-
ular mechanisms underlying TRPM7-dependent actions using bone
marrow-derived macrophages (BMDM).
2. Methods
Please see Supplementary material online for detailed methods.
2.1 Animals
Animal experiments were performed in accordance with the United
Kingdom Animals Scientific Procedures Act 1986 and ARRIVE
Guidelines and approved by the institutional ethics review committee.
We used male, 18- to 22-week-old mice. Wild-type (WT) TRPM7þ/þ
mice (C57BL/6J and SV129 mixed background) and mice heterozygous
for the deletion of the TRPM7-kinase (TRPM7þ/Dkinase), generated by
the gene-targeting vector technique were studied.10 After study, all ani-
mals were anaesthetized by isoflurane inhalation (3%) plus 1 L/min O2
and then euthanized by exsanguination. TRPM7þ/Dkinase mice have been
characterized and compared with WT mice have significantly lower
Mg2þ concentration in plasma, urine, and bones likely due to decreased
functional channel activity, and survival is reduced.10
2.2 Echocardiography
Animals were anaesthetized by isoflurane inhalation (2.5%) plus 1 L/min
O2. Cardiac function and structure were assessed by echocardiography
using an Acuson Sequoia c512 ultrasound system to acquire non-
invasive 2D guided M-mode images at a 20mm depth at the tip of the
papillary muscles.
2.3 Plasma and urine biochemistry
Blood was collected under isoflurane anaesthesia by cardiac puncture
immediately prior to sacrifice. Spot urine was collected from the bladder.
Calcium, phosphate, sodium, potassium, chloride, magnesium, albumin,
creatinine, plasma total cholesterol, HDL, and glucose were determined
by automated methods.
2.4 Intra-vital microscopy to assess
vascular inflammatory responses in vivo
Mice were injected with 20ng of recombinant murine TNFa to induce a
mild inflammatory response. Mice were anaesthetized by isoflurane inha-
lation (3%) plus 1 L/min O2. Cremaster muscle was prepared for intra-vi-
tal microscopy as described.24 Vessels between 25 and 35mm were
randomly selected from different areas of the tissue. Videos were
recorded for 60 s. Leucocyte rolling velocity, adhesion, and transmigra-
tion were analysed.
2.5 Flow cytometry
Cells from heart, kidney, and spleen were labelled with cell surface
markers using the following specific antibodies: anti-CD45-FITC
(30-F11), anti-CD3-PE-Cy7 (145-2C11), anti-CD4-APC (GK1.5), anti-
CD8-APC-Cy7 (53-6.7), anti-CD19-PerCP-Cy5.5 (6D5), anti-F4/80-
Alexa-647 (BM8), anti-CD11c-PE-Cy7 (N418), anti-CD206-FITC
(C068C2), anti-CD206-PE (C068C2), anti-CD11b-Alexa 647 (M1/70),
anti-Ly-6C-APC/Cy7 (HK1.4), and anti-CD45-PE (30-F11).
2.6 Mg2þ and Ca2þ concentration
Total Mg2þ concentration in hearts and kidneys was assessed using the
Magnesium Gen.2 kit. Measurement of intracellular free Mg2þ concen-
tration ([Mg2þ]i) and intracellular free Ca
2þ concentration ([Ca2þ]i)
were assessed by magnesium green AM and Cal-520 AM, respectively.
2.7 Culture of BMDM and isolation of
resident peritoneal macrophages
Animals were anaesthetized by isoflurane inhalation (5%) plus 1 L/min
O2 and then euthanized by cervical dislocation. BMDMwere obtained as
previously described.25 Resident peritoneal macrophages were har-
vested from the peritoneal cavity of mice by lavage with cold phosphate
buffered saline.
2.8 Culture of cardiac fibroblasts
Hearts were cut into small pieces, digested with collagenase II, and the
cell suspension centrifuged. The resulting pellet was re-suspended in
Dulbecco’s modified Eagle’s medium/20% fetal bovine serum, adherent
cells cultured and low passage cells studied.
2.9 Immunoblotting
Expression of proteins was detected using specific antibodies targeted
to: fibronectin, a-smooth muscle actin (a-SMA), b-actin, TGFb1,
annexin-1, calpain-II, galectin-3, proliferating cell nuclear antigen
(PCNA), spectrin aII, a-tubulin, vimentin, GAPDH, Na/K ATPase,
phospho-Stat3, phospho-Stat1, phospho-Smad3, and phospho-p66Shc.
Protein expression was visualized using secondary fluorescence-coupled
antibodies.
2.10 Cytosol and membrane fractionation
Translocation of annexin-1 and calpain-II from the cytosol to the mem-
brane was assessed in cardiac tissues as a marker of TRPM7 kinase activ-
ity, since these proteins are downstream targets of TRPM7 kinase.
Cytosolic and membrane fractions were obtained by ultracentrifugation.
2.11 Real-time reverse-transcription
polymerase chain reaction
Total RNA was isolated, cDNA was generated from total RNA and real-
time polymerase chain reaction performed with specific murine primers
to GAPDH, fibronectin, collagen-1, TGFb1, TNFa, IL-1b, IL-12, IL-10,
Arg1, iNOS, IFN-c, VCAM-1, MMP2, and TIMP-1.
2.12 Histology
Hearts, aortas, and kidneys were fixed and processed for histological ex-
amination by light microscopy (haematoxylin and eosin, picrosirius red).
Fibrosis was further analysed in picrosirius red-stained samples using
bright field and polarized light microscopy. Tissue fibrosis was also quan-
tified using second harmonic generation (SHG)/two photon excitation
fluorescence.
2.13 Immunohistochemistry
Mouse heart sections were deparaffinized and processed for antigen re-
trieval. Slides were incubated with the primary antibody anti-galectin-3
and secondary antibodies and counterstained with haematoxylin.
TRPM7 is cardiovascular protective 723
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2.14 Enzyme-linked immunosorbent assay
kits
Plasma galectin-3 levels were analysed by enzyme-linked immunosor-
bent assay (ELISA). Cytokine production was analysed in macrophage
supernatant by ELISA (IL-6, IL-10, IL-12, TNF-a).
2.15 MgL and MgH vascular smooth muscle
cells26
In some experiments, VSMCs frommice with genetically low body Mg2þ
(MgL) or high body Mg2þ (MgH) were used. These mice have been well
characterized.26,27
2.16 Statistical analysis
Data are presented as mean ± SEM. Two-tailed unpaired Student’s t-test
was used when differences between two groups were analysed. Analysis
of variance (ANOVA) and the Student–Newman–Keuls post-test were
used to evaluate statistical significance of differences between three or
more groups. Significance was assumed if P<0.05.
3. Results
3.1 Plasma and urine biochemistry
Plasma electrolytes were not significantly different between groups
(Supplementary material online, Table S2). Urinalysis showed lower lev-
els of magnesium, potassium, phosphate, and chloride in the experimen-
tal group (Supplementary material online, Table S2). TRPM7þ/Dkinase
mice had increased plasma levels of total cholesterol and reduced levels
of HDL cholesterol (Supplementary material online, Table S2).
Galectin (Gal)-3 is a b-galactoside-binding lectin secreted by activated
macrophages and is a biomarker for both cardiac inflammation and
fibrosis.28 TRPM7þ/Dkinase (M7þ/D) mice had significantly elevated levels
of plasma Gal-3 (Supplementary material online, Table S2).
3.2 Tissue and cellular magnesium status in
TRPM7þ/Dkinase mice
Total Mg2þ levels were lower in heart and kidneys from TRPM7þ/Dkinase
mice vs. WT controls (Figure 1A). Cardiac and renal macrophages and
circulating monocytes from TRPM7þ/Dkinase mice had 30–50% reduction
in [Mg2þ]i compared with cells fromWT controls (Figure 1B, C).
Intracellular concentration of Mg2þ was not associated with macro-
phage phenotype because there were no significant differences in
[Mg2þ]i betweenM1 (F4/80þCD11cþ) and M2 (F4/80þCD206þ) mac-
rophages in bothWT and TRPM7þ/Dkinase mice (Supplementary material
online, Figure S2A, B). Macrophage [Ca2þ]i was not significantly different
between groups (Figure 1D, E).
3.3 Expression of TRPM6 and TRPM7
There were no differences in gene expression for TRPM7 in hearts and
kidneys betweenWT and TRPM7þ/Dkinase mice (Supplementary material
online, Figure S2C, D). mRNA expression of TRPM6 was increased in kid-
neys and reduced in hearts in TRPM7þ/Dkinase mice (Supplementary ma-
terial online, Figure S2E, F).
Protein expression of the kinase domain was reduced in TRPM7þ/
Dkinase mice in hearts and kidneys (Supplementary material online, Figure
S3A, B). This was associated with decreased TRPM7 phosphorylation
and reduced expression of TRPM7 channel (Supplementary material on-
line, Figure S3C, D).
3.4 Cardiac morphology and function
TRPM7þ/Dkinase mice had significantly larger hearts than WT controls
(Figure 2A). Cardiac analysis by echocardiography demonstrated reduced
early (E)/late (A) [(E/A)] diastolic filling velocities, indicative of cardiac
stiffening (Figure 2B, E). We did not observe differences in fractional
shortening or anterior wall thickness (AWT) between groups (Figure
2C–E).
3.5 TRPM7 deficiency is associated with
cardiac fibrosis
TRPM7þ/Dkinase mice had cardiac hypertrophy and increased fibrosis as
evidenced by approximately three-fold increase in collagen content.
Sirius red staining using bright field and polarized light microscopy,
showed increased deposition of total collagen, mature collagen (red fluo-
rescence), and immature collagen (green fluorescence) (Figure 2F–H,
Supplementary material online, Figure S4A, B). Cardiac fibrosis was also
observed by SHGmethodology, where collagen is determined by the in-
tensity of green autofluorescence (Supplementary material online, Figure
S4C). Expression of cardiac fibronectin was increased 2.8-fold in
TRPM7þ/Dkinase mice (Figure 2I). Molecular mechanisms related to fibro-
genesis typically involve TGF-b production, which signals through
Smad3.29 We found that hearts from TRPM7þ/Dkinase mice exhibited
high expression of TGF-b (2.3-fold) and associated increased phosphor-
ylation of Smad3 (two-fold) compared with WT mice (Figure 2J, K).
Consistent with these findings, TRPM7 deficiency resulted in upregula-
tion of gene expression of TGFb1, collagen-I, and fibronectin
(Supplementary material online, Figure S4D–F), and increased phosphor-
ylation of p66Shc, which is involved in cardiovascular injury
(Supplementary material online, Figure S4G).
3.6 Cardiac inflammation and TRPM7
signalling
Fibrosis is often associated with inflammation, and may be a consequence
of dysregulated inflammatory responses. Hearts from TRPM7þ/Dkinase
mice exhibited increased gene expression of TNFa and IL-12, potent
pro-inflammatory cytokines and of IL-10 and Arg1, important proteins in
the resolution phase of inflammation, tissue repair, and fibrosis (Figure
3A). TRPM7þ/Dkinase mice had increased cardiac inflammatory cell infiltra-
tion visualized by HE staining and confirmed by the increased presence
of CD45þ cells (Figure 3B, C), and F4/80þCD206þmacrophages (Figure
3D–F), a phenotype present in scar tissue and important in resolution of
inflammation and fibrosis. They also had an increase content of CD3þ
cells and CD8þ T cell but not CD4þ T cells or B cells (Supplementary
material online, Figure S5A–D). Phosphorylation of the transcription fac-
tors Stat1 and Stat3 is critically involved in inflammation and fibrosis.13
Cardiac phosphorylation of Stat1, but not Stat3, was increased in
TRPM7þ/Dkinase mice compared with WT animals (Figure 3G, H). In addi-
tion, cardiac expression of galectin-3 was increased in TRPM7þ/Dkinase
mice (Figure 3I, J).
Annexin-1 and calpain-II (m-calpain), which translocate to the cell
membrane upon activation, are known targets for TRPM7 a-kinase.16,30–
33. Cardiac expression of calpain-II and translocation from the cytosol to
the membrane were increased in TRPM7þ/Dkinase mice as evidenced by
increased membrane: cytosolic expression (Figure 4A–C, G). Cardiac ex-
pression and activity of annexin-1 were unaltered in hearts from
TRPM7þ/Dkinase mice (Figure 4D–F, H).
Calpain-II activity was further evaluated by assessing cleavage of spec-
trin a II (a-fodrin), a cytoskeletal protein sensitive to calpain-II
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creased in hearts from TRPM7þ/Dkinase mice.
3.7 Increased leucocyte transmigration and
inflammation in vessels in TRPM7þ/Dkinase
mice
To assess vascular functional and inflammatory responses in TRPM7þ/
Dkinase mice, we performed intra-vital microscopy in cremasteric venules
(Figure 5A). TRPM7þ/Dkinase mice showed reduced rolling velocity (by
55%) (Figure 5B), with strong adhesion (200%) (Figure 5C), and neutrophil
transmigration into the vascular wall (450%) (Figure 5D) compared with
WT mice. Together, these findings demonstrate that TRPM7 deficiency
leads to a pro-inflammatory condition in vessels characterized by neu-
trophil: endothelial adhesion and transmigration into the vascular media
and perivascular tissue.
The inflammatory phenotype was also observed in aorta from
TRPM7þ/Dkinase mice, which had higher mRNA expression of VCAM-1
(25-fold), IL-12 (6.8-fold), iNOS (12-fold), and Arg1 (18-fold) (Figure 5E).
Markers of vascular fibrosis including collagen deposition
(Supplementary material online, Figure S6A–C) and gene expression for
collagen-1, fibronectin, TGFb1, and TIMP1/MMP2 (Supplementary
Figure 1 Tissue and cellular Mg2þ and Ca2þ levels in TRPM7þ/Dkinase mice. (A) Total Mg2þ concentration in heart and kidneys from WT (n=9) and
TRPM7þ/Dkinase (M7þ/D) (n=13) mice was assessed by colorimetric assay and normalized by dry weight. Total mononuclear leucocytes were isolated from
hearts, kidneys, and blood, and labelled with magnesium green AM (Mg2þ green), followed by specific antibodies: anti-CD45þ anti-F4/80 for macrophage
identification in heart and kidney, and anti-CD11bþ anti-Ly6C for bloodmonocytes. (B) Representative flow cytometry histograms and corresponding scat-
ter-plot graphs (C) showing free Mg2þ levels in macrophages isolated from hearts (n=6/group) and kidneys and blood monocytes (n=6/group). (D, E)
Intracellular free Ca2þ levels in macrophages were investigated using the probe Ca-520 and analysed by flow cytometry (n=6/group). Data are presented
as representative flow cytometry histograms (D) and corresponding scatter-plot graphs (E). Results are mean ± SEM of mean of fluorescence intensity (MFI)
of fluorescence-labelled cells assessed by flow cytometry. Statistical significance was determined by a two-tailed unpaired Student’s t-test. *P<0.05
TRPM7þ/Dkinase (M7þ/D, blue) vs. WT (yellow).
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Figure 2 Cardiac dysfunction and fibrosis in TRPM7þ/Dkinase mice. (A) Heart weight, normalized to tibia length, in WT and TRPM7þ/Dkinase (M7þ/D) mice
(n = 8/group). (B–E) Echocardiography analysis showing ventricular filling velocity assessed by E/A ratio (B), where Early-E and late atrial-A ventricular filling
velocity; (C) Left ventricular fractional shortening (FS%); (D) left ventricular AWT (WT n = 7, M7þ/D n = 8); (E) Representative images by M-mode echocar-
diography (upper panel) and Doppler (lower panel). (F) Cardiac sections obtained fromWT and M7þ/D were stained with sirius red and collagen content
assessed using bright field (scale bar 10 lm) and polarized light (scale bar 200 lm). Images are representative of n = 6/group. Collagen was analysed in bright
field (F, H-upper panel) and polarized light (G, H-lower panel) and data expressed as mean ± SEM of % affected area (n = 6/group). Cardiac pro-fibrotic
markers were assessed by immunoblotting: (I) fibronectin (n = 5/group), (J) TGFb (n = 5/group), and (K) phospho-Smad3 (Tyr179) (n = 6/group). Proteins
of interest were normalized to a-tubulin. Statistical significance was determined by a two-tailed unpaired Student’s t-test. *P < 0.05 TRPM7þ/Dkinase (M7þ/D,
blue) vs.WT (yellow).
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Figure 3 Cardiac inflammation in TRPM7þ/Dkinase mice. Total RNA was obtained from total cardiac tissues and gene expression for TNFa, IL-12, IL-10,
iNOS, Arg-1, and IL-1b was determined by real-time PCR and normalized by GAPDH (A). Data are expressed in 2-DDCt values (WT n = 6, M7þ/D n = 8).
(B) Histological sections from hearts tissues from WT and TRPM7þ/Dkinase (M7þ/D) mice stained with H&E showing an inflammatory infiltrate. The
highlighted area in (B) shows the inflammatory infiltrate. Images are representative photomicrographs (n = 8/group), scale bar = 150 lm. Total leucocytes
were isolated from hearts by enzymatic digestion and stained for flow cytometry analysis. (C) CD45þ population (total haematopoietic cells), (D)
CD45þF4/80þ cells (macrophages); (E) CD45þF4/80þCD206þ (M2 macrophages); (F) CD45þF4/80þCD11c (M1 macrophages) (n = 6/group). Total
lysates obtained from cardiac tissues were investigated for the expression of (G) phospho-Stat1 (Tyr701) and (H) phospho-Stat3 (Tyr705) by western blot-
ting and normalized to total Stat1 and Stat3, respectively (n = 6/group). (I, J) Increased galectin-3 expression in the hearts of TRPM7þ/Dkinase mice. (I)
Representative histological sections obtained from hearts fromWT and TRPM7þ/Dkinase mice (n = 5/group). Controls for immunoreactivity were assessed
using the isotype only. (J) Corresponding scatter-plot graphs indicating galectin-3 expression by immunohistochemistry. Scale bar = 150 lm (n = 5/group).
Results are mean ± SEM. Statistical significance was determined by a two-tailed unpaired Student’s t-test. *P < 0.05 TRPM7þ/Dkinase (M7þ/D, blue) vs. WT
(yellow).
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Figure 4 Cardiac calpain-II and annexin-1, downstream targets of TRPM7, in TRPM7þ/Dkinase mice. Cardiac expression of Calpain-II and Annexin-1
(ANXA-1) in total heart lysate (A, D) (n=6/group), cytosolic (B, E) and membrane fractions (C, F) (n=7/group) assessed by immunoblotting. Cytosolic and
membrane fractions from total cardiac tissues were obtained by ultracentrifugation. Protein expression in total lysate and cytosolic fractions were normal-
ized to a-tubulin and the membrane fraction was normalized to Na-K ATPase content. The ratio of membrane: cytosolic calpain-II (G) and annexin-1 (H) is
used as an index of cytosol to membrane translocation. (I) Total lysates from cardiac tissues were used to assess expression of spectrin a II, total (240 kDa)
and cleaved forms (110kDa), by western blotting and further normalized to a-tubulin (n=6/group). Results are presented as representative immunoblots
and corresponding scatter-plot graphs. Data are means ± SEM. Statistical significance was determined by a two-tailed unpaired Student’s t-test *P<0.05
TRPM7þ/Dkinase (M7þ/D, blue) vs. WT (yellow).
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..material online, Figure S6D–G) were not different between TRPM7þ/
Dkinase andWTmice.
3.8 TRPM7 deficiency is associated with
inflammatory/immune cell infiltration in
kidneys
Uncontrolled inflammatory cell migration into tissues is an important
process underlying renal damage. Kidneys from TRPM7þ/Dkinase mice
exhibited increased inflammatory infiltration as determined by haema-
toxylin-eosin staining (Figure 6A), which was confirmed by flow
cytometry, that showed a approximately four times increase in the total
number of haematopoietic CD45þ cells in kidneys from TRPM7þ/Dkinase
mice vs. WT controls (Figure 6B, C). Characterization of the immune cell
infiltrate showed that kidneys from TRPM7þ/Dkinase mice had increased
CD4þ T lymphocytes and macrophages (F4/80þ cells) (Figure 6D–G).
The B cell population was reduced in kidneys from TRPM7þ/Dkinase ani-
mals (Supplementary material online, Figure S7A, B). Renal macrophages
from TRPM7þ/Dkinase were typically pro-inflammatory evidenced by the
increased ratio of CD11c/CD206 expression markers (Figure 6H–J) and
IL-12/IL10 mRNA (Figure 6K) and higher expression of MCP-1 mRNA
(Figure 6L), which is a chemokine involved in monocyte migration.
Figure 5 Increased vascular inflammation in TRPM7þ/Dkinase mice. (A) Intra-vital images obtained from cremasteric microvessels 3 h after intrascrotal injec-
tion of TNFa (20 ng/mL). Images are representative bright field ofWT (left panel) and TRPM7þ/Dkinase (M7þ/D) (right panel) animals. Yellow arrows indicate
transmigrated cells, scale bars = 25lm. Images were recorded for 60 s from at least eight vessels from each animal (n=4/group) and analysed for (B) rolling
velocity, (C) number of adherent cells, and (D) number of transmigrated cells and normalized by 100 lm2. Data are presented as mean ± SEM. (E) Total
RNA was obtained from aorta and gene expression for VCAM-1, IL-12, IL-10, iNOS, and Arg-1 was determined by real-time PCR and normalized to
GAPDH expression. Data are expressed in 2-DDCt values (n=6–7/group). Data are means ± SEM. Statistical significance was determined by a two-tailed un-
paired Student’s t-test. *P<0.05 TRPM7þ/Dkinase (M7þ/D) (blue) vs.WT (yellow).
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mRNA expression for TNFa, IFNc, IL-1b, and fibrotic markers collagen-
I, TGFb, and fibronectin was similar in kidneys from WT and TRPM7þ/
Dkinase animals (Supplementary material online, Figure S7C–J). Together
these data indicate that kidneys from TRPM7þ/Dkinase animals have low-
grade inflammation indicated by the high inflammatory infiltration, M1
macrophages and increased population of CD4þ T cells. However, kid-
ney injury at this stage does not seem to be associated with significant
fibrosis.
3.9 Systemic inflammation in
TRPM7þ/Dkinase mice
Inflammatory infiltration in organs is usually associated with systemic in-
flammation. We found a 45% reduction in spleen weight in TRPM7þ/
Dkinase animals (Supplementary material online, Figure S8A, B) which is
typically observed in auto-immune disorders.34 Spleens from TRPM7þ/
Dkinase animals had a higher total number of immune cells (3.7  108
cells/mg) compared with WT (2.0  108 cells/mg) (Supplementary
Figure 6 Renal inflammation in TRPM7þ/Dkinase mice. (A) Representative photomicrographs of histological kidney sections stainedwith H&E (n=8/group).
The highlighted area in (A) shows the inflammatory infiltrate. Scale bar = 150lm. Total leucocytes were isolated from kidneys by enzymatic digestion and
stained for flow cytometry analysis. Results are shown as representative plots and as mean ± SEM (WT n=8, M7þ/D n=10) of (B, C) CD45þ population
(total haematopoietic cells); (D) CD45þCD3þCD4þ cells (CD4 T lymphocytes); (E) CD45þCD3þCD8þ cells (CD8 T lymphocytes) (n=6/group); (F,
G) CD45þF4/80þ cells (macrophages); (H) CD45þF4/80þCD11cþ (M1 macrophages); (I) CD45þF4/80þCD206þ (M2 macrophages); (J, K) CD11c to
CD206 ratio (WT n=7, M7þ/D n=9) and IL-12 to IL-10 mRNA ratio; (L) MCP-1 mRNA gene expression (WT n=7, M7þ/D n=9). Statistical significance
was determined by a two-tailed unpaired Student’s t-test. *P<0.05 TRPM7þ/Dkinase (M7þ/D, blue) vs.WT (yellow). SSC-A, Side-Scatter.
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material online, Figure S8C) and higher percentage of CD4þ and CD8þ
T lymphocytes (Supplementary material online, Figure S8D, E). TRPM7þ/
Dkinase exhibited higher frequency of splenic macrophages and similar to
what was observed in kidneys macrophages showed a pro-inflammatory
M1 phenotype, with an increase in the ratio of CD11c/CD206 expres-
sion markers (Supplementary material online, Figure S8F, G). B cell popu-
lation was similar in both groups (Supplementary material online, Figure
S8H). Spleens from TRPM7þ/Dkinase animals also exhibited increased
mRNA expression of the pro-inflammatory markers IFN-c and IL-6 and
reduced expression of the anti-inflammatory cytokine IL-10
(Supplementary material online, Figure S8I–K). Protein expression of pro-
fibrotic markers fibronectin and TGFb was also increased in splenic tis-
sues from TRPM7þ/Dkinase animals (Supplementary material online, Figure
S8L, M). Blood monocytes can be identified as pro- or anti-inflammatory
by high or low expression of marker Ly6C, respectively.35 We found
that TRPM7þ/Dkinase and WT animals presented similar frequencies of
Ly6Chigh and Ly6Clow cells (Supplementary material online, Figure S9A–
C).
3.10 TRPM7-deficient BMDM induce a fi-
brotic and proliferative phenotype in car-
diac fibroblasts: effects of MgCl2 treatment
BMDM from TRPM7þ/Dkinase mice showed increased production of Gal-
3, IL-10, and IL-6 as determined by western blot from the cell lysate and
ELISA from the cell supernatant (Figure 7A–C, Supplementary material
online, Figure S10D). These cells also had increased expression of
calpain-II (Supplementary material online, Figure S10A, B). Treatment of
macrophages with MgCl2 increased [Mg
2þ]i (Supplementary material on-
line, Figure S10C, D) and reduced the production of Gal-3 and IL-10 only
in macrophages from TRPM7þ/Dkinase mice (Figure 7A–C). Similar to
BMDM, isolated resident peritoneal macrophages from TRPM7þ/Dkinase
animals produced higher concentrations of IL-10, IL-6, and TNFa com-
pared withWT animals (Supplementary material online, Figure S11A–D).
To evaluate the functional significance of TRPM7-deficient macro-
phages, we assessed pro-fibrotic effects of TRPM7þ/Dkinase macrophages
on WT cardiac fibroblasts in a co-culture system using the transwell ap-
proach (Figure 7E). As shown in Figure 7F–H (Supplementary material on-
line, Figure S12A, B) co-culture of cardiac fibroblasts with TRPM7þ/Dkinase
macrophages increased expression of fibronectin, PCNA, and TGFb,
proteins involved in the extracellular matrix and cell proliferation.
Importantly, these effects were ameliorated when macrophages were
treated with MgCl2. Similar effects were observed when cardiac fibro-
blasts were treated only with supernatants of macrophages
(Supplementary material online, Figure S13A–E), indicating that macro-
phages from TRPM7þ/Dkinase mice produce soluble factors that promote
a pro-fibrotic phenotype in cardiac fibroblasts through Mg2þ-dependent
mechanisms.
3.11 Increased expression of pro-
inflammatory and pro-fibrotic markers in
vascular smooth muscle cells from mice
with low Mg2þ (MgL)
To further confirm the relationship between low Mg2þ and vascular fi-
brosis and inflammation, we studied another experimental model, specif-
ically VSMCs from mice with genetically low Mg2þ (MgL) or high Mg2þ
(MgH). These mice have been well characterized.26,27 As shown in
Supplementary material online, Figure S14, expression of fibronectin and
TGFbwas significantly greater in MgL vs. MgH cells.
4. Discussion
Major findings from our study show that TRPM7þ/Dkinase mice exhibit
cardiovascular inflammation and fibrosis, processes associated with ab-
normal macrophage activation and intracellular Mg2þ deficiency. The
pro-fibrotic and pro-inflammatory effects of reduced TRPM7 function
are mediated in part throughMg2þ-dependent mechanisms, because cel-
lular Mg2þ treatment ameliorated deleterious effects in cardiac fibro-
blasts exposed to TRPM7þ/Dkinase BMDM. Together our data suggest
that TRPM7 protects against inflammatory responses and fibrosis in the
cardiovascular system.
TRPM7 and its homologue TRPM6 are unusual bifunctional molecules.
The channel is permeable primarily to Mg2þ as well as Ca2þ and Zn2þ,
whereas the a-kinase domain activates downstream target proteins in-
volved in cytoskeleton organization, cell proliferation, inflammatory
responses, and vascular contraction among other properties.1,2 While
some studies suggested that a functional a-kinase domain is necessary
for TRPM7 channel-mediated cation influx,10,36,37 others reported that
the a-kinase domain is not required.6,11 Here, we show that TRPM7þ/
Dkinase cells have lower intracellular Mg2þ levels compared withWT con-
trol counterparts, supporting the notion that the kinase domain may in-
fluence the channel domain. This was further supported by our findings
that phosphorylation of TRPM7 channel was reduced in TRPM7þ/Dkinase
mice. These findings are in line with electrophysiology studies that
showed decreased TRPM7 current in mast cells from TRPM7þ/Dkinase
mice.10
TRPM7-deficient mice exhibited an inflammatory phenotype charac-
terized by increased production of chemokines and pro-inflammatory
cytokines and increased migration of macrophages into the heart, ves-
sels, and kidneys. In addition to systemic inflammation, TRPM7þ/Dkinase
mice had hypercholesterolaemia with reduced HDL levels. The exact
cause of this metabolic derangement is unclear, but may relate to im-
paired cellular Mg2þ homeostasis and altered lipid metabolism associ-
ated with liver inflammation. Although we did not examine the liver in
our study, previous studies showed an association between Mg2þ, NF-
jB/NLRP3 inflammasome activation and lipid metabolism.38
Monocytes/macrophages are cells of the innate immune system.
Uncontrolled activation promotes tissue injury and fibrosis. These cells
differentiate into classically activated M1 macrophages that are associ-
ated with pro-inflammatory responses and tissue destruction, whereas
alternative activated or M2 macrophages regulate the inflammatory re-
sponse and tissue repair, depending on the microenvironment.39 Both
macrophage populations co-exist in tissues and participate in
fibrogenesis.39 Our results show a significant inflammatory response in
the heart and kidneys of TRPM7þ/Dkinase mice, characterized primarily by
increased populations of macrophages, CD4þ T cells and CD8þ T cells.
Whereas macrophages in the heart were mainly of the CD206-
expressing M2 phenotype, those in the kidney were primarily CD11c-
expressingM1macrophages. M1macrophages release mediators, includ-
ing ILs, TNFa, and reactive oxygen species, which stimulate inflammatory
signalling pathways causing tissue injury. In contrast, M2 macrophages re-
lease factors that modulate both inflammation and fibrosis including IL-
10, galectin-3, and TGF-b.39
In addition to altered T cells, B cell status was modified in TRPM7-
deficient mice. In particular, the number of B cells was reduced in kidneys
from TRPM7þ/Dkinase mice. This may relate to impaired maturation of B
cells because TRPM7 has been shown to play an important role in B cell
maturation.40 Since B cells are responsible for protective antibody pro-
duction, the reduced levels in TRPM7-deficient mice might further
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Figure 7 TRPM7þ/Dkinase macrophages induce a fibrotic phenotype in cardiac fibroblasts fromWTmice: effects of MgCl2 treatment. BMDM were differ-
entiated from TRPM7þ/Dkinase (M7þ/D) andWTmice and treated with MgCl2 (10mM) for 24h. (A) Total cell lysate was analysed for Galectin-3 expression
by immunoblotting and normalized to GAPDH protein expression. The production of (B) Galectin-3, and (C) IL-10 was analysed in the macrophage super-
natant by ELISA (n=7–8/group). (E) Primary culture cardiac fibroblasts fromWTmice were co-cultured in transwell systemwith macrophage fromM7þ/D
andWT animals, treated or not with MgCl2. After 48h stimulation, the total cell lysate was obtained from cardiac fibroblasts and expression of (F) fibronec-
tin (n=8/group) (G) PCNA (n=9/group), and (H) TGFb (n=9/group) was analysed by western blotting and normalized to b-actin. Data are presented as
representative immunoblots and corresponding scatter-plot graphs. Results are mean ± SEM of M7þ/D (blue) andWT (yellow). Statistical significance was
determined by one-way ANOVA using the Student–Newman–Keuls post-test. *P<0.05 for TRPM7þ/Dkinase (M7þ/D) compared withWTmice. †TRPM7þ/
Dkinase treated with MgCl2 vs. untreated TRPM7
þ/Dkinase.
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contribute to renal inflammation and injury. The effect seems to be
tissue-specific because there were no differences in the number of B
cells in spleens and hearts betweenWT and TRPM7þ/Dkinase mice.
Our findings identified distinct inflammatory/fibrogenic responses in
the heart and kidney in TRPM7-deficient mice. While exact reasons for
this are unclear, a number of factors may play a role. Firstly, the origin of
macrophages may be important because those in fibrotic hearts derive
from the splenic reservoir and bone marrow41 whereas macrophages
from kidneys derive only from the bone marrow.35 Secondly, inflamma-
tion and fibrosis are dynamic processes and perhaps the disparity in the
heart and kidney reflects different phases of tissue injury. Finally, the
presence of TRPM6 in the kidney but not in the heart, may modulate
TRPM7 function and inflammatory responses. In support of this, we
found increased TRPM6 expression in kidneys but not in hearts from
TRPM7þ/Dkinase mice.
The inflammatory response was not restricted to immune cells since
TRPM7-deficient mice had increased vascular expression of the adhesion
molecule ICAM-1, which promotes adhesion of pro-inflammatory neu-
trophils. The functional significance of this was assessed in vessels in situ
in real time by intra-vital microscopy, which showed that TRPM7þ/Dkinase
mice exhibited reduced neutrophil rolling, increased neutrophil: endo-
thelial adhesion and enhanced transmigration into the vascular media
and perivascular tissue in response to low-dose TNFa. These processes,
together with activation of macrophages in the vascular wall are critically
involved in triggering the vascular response in atherosclerosis, hyperten-
sion, and diabetes. The importance of TRPM7 in neutrophil migration
and infiltration has previously been demonstrated in human neutrophil
cell lines42 and sepsis-induced lung injury in rats.43
Chronic inflammation predisposes to fibrosis and target organ dam-
age. In the heart, fibrosis causes cardiac enlargement and stiffening, ven-
tricular dysfunction and ultimately cardiac failure. These processes are
accelerated with aging. TRPM7-deficient mice exhibited cardiac hyper-
trophy and abnormal function assessed by echocardiography. These
changes were associated with increased collagen deposition, enhanced
expression of fibronectin and TGFb and phosphorylation of Smad3,
which is downstream of TGFb, indicating marked cardiac fibrosis.
Molecular mechanisms whereby TRPM7-kinase deficiency causes fibrosis
may relate to activated macrophages as well as dysregulation of
downstream TRPM7 downstream targets, especially annexin-1 and cal-
pain-II.4,44 Annexin-1 is anti-inflammatory45 whereas calpain-II has pro-
inflammatory and pro-fibrotic properties.46 Calpain activation is directly
involved in cardiac hypertrophy and inflammation through pathways
involving NF-kB, NFAT, and TGF-b.47 We found increased calpain-II ac-
tivity in TRPM7þ/Dkinase mice as evidenced by increased membrane: cyto-
sol expression and cleavage of spectrin a-II. These data are in contrast to
our previous findings and those of others, which demonstrated blunted
calpain activity when TRPM7 is downregulated.11 However, most previ-
ous studies were performed in cell-based systems, which do not reflect
intact systems in vivo. Moreover, increased calpain-II activity may be sec-
ondary to the inflammatory state in TRPM7þ/Dkinase mice.
Levels of Gal-3 were increased in plasma and cardiac tissue of
TRPM7-deficient mice. Gal-3 is produced mainly by macrophages and
activates fibroblasts to proliferate and produce collagen-I, TGFb, and
other pro-fibrotic markers such as a-smooth muscle actin (a-SMA).14,48
Clinically plasma Gal-3 is a biomarker of heart failure and cardiac
fibrosis28 and in rats injected with intra-pericardial Gal-3 the heart
undergoes remodelling and fibrosis.49 Gal-3 is also involved in tissue in-
flammatory cell infiltration and leucocyte recruitment to tissues.50
Differentiated macrophages from TRPM7þ/Dkinase mice produced higher
levels of Gal-3, IL-6, and IL-10, which are also involved in cardiac fibrosis.
Gal-3 mediates effects through Stat1 and Stat3.13,51,52 In TRPM7þ/Dkinase
hearts, phosphorylation of Stat1, but not Stat3, was significantly in-
creased. Whether this is due to a direct effect of decreased TRPM7 ki-
nase activity or secondary to macrophage activation remains unclear.
The pro-fibrotic phenotype of TRPM7þ/Dkinase macrophages is further
evidenced by the findings that these cells induced expression of fibronec-
tin and PCNA in cardiac fibroblasts from WT animals in a Mg2þ-
dependent manner.7
Our study contributes to the growing evidence that TRPM7 is a new
player in immune cell regulation and inflammation as recently highlighted
by Nadolni and Zierler53and Santoni et al.54 To our knowledge, we pro-
vide the first comprehensive evidence defining a regulatory role for
TRPM7 in cardiovascular inflammation and fibrosis. While we identify
TRPM7 as being protective in line with its fundamental and non-
redundant role in cellular physiology and viability,2,10, others suggest that
TRPM7 activation causes dysregulated immune responses and inflamma-
tion and that TRPM7 inhibition may have therapeutic potential in
pro-inflammatory diseases and immune hypersensitivity.43,55 These dis-
crepancies likely depend on the relative contributions of TRPM7 channel
vs. kinase and highlight the complexity of the system.
In summary, our data show a distinct pro-inflammatory and pro-fi-
brotic cardiovascular and renal phenotype in TRPM7þ/Dkinase mice, pro-
cesses linked to macrophage activation, increased signalling through
Smad3, calpain-II, and Stat1 and cellular hypomagnesaemia. Taken to-
gether, these findings suggest that TRPM7 has anti-inflammatory and
anti-fibrotic functions, at least in the model studied. We define a novel
and important protective role of TRPM7 in cardiovascular inflammation,
organ injury and cardiac fibrosis, cellular responses that involve immune
cell activation mediated, in part, throughMg2þ-dependent processes.
Supplementary material
Supplementary material is available at Cardiovascular Research online.
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Translational Perspectives
Mg2þ is an essential cation that influences vascular tone, cardiac contractility, and immune cell function. Mg2þ homeostasis is regulated by cation trans-
porters, particularly TRPM7. Clinically, hypomagnesaemia is associated with cardiovascular disorders including arrythmias, hypertension, and vascular
calcification, processes that involve vascular dysfunction, inflammation and fibrosis. Molecular mechanisms driving Mg2þ-related cardiovascular dis-
ease are elusive, but altered TRPM7 function may be important. Our study revealed that downregulation of TRPM7 and consequent intracellular
Mg2þ deficiency promotes cardiovascular inflammation and fibrosis. These findings suggest that the TRPM7/Mg2þ pathway is cardiovascular protec-
tive and may be a novel therapeutic target in cardiovascular disease.
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